Related Experiment Video

Updated: Feb 7, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

417

Targeted Molecular Treatments in Non-Small Cell Lung Cancer: A Clinical Guide for Oncologists

Kim Tam Bui1, Wendy A Cooper2,3,4, Steven Kao5,6

  • 1Chris O'Brien Lifehouse, 119-143 Missenden Road Camperdown, Camperdown, NSW 2050, Australia. kimtam.bui@lh.org.au.

Journal of Clinical Medicine
|August 2, 2018
PubMed

Insights

Targeted therapies for non-small cell lung cancer (NSCLC) use specific mutations like EGFR, ALK, BRAF, and ROS1 to guide treatment. This review covers their efficacy, resistance, and safety.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Non-small cell lung cancer (NSCLC) management has been transformed by targeted molecular therapies.
  • Specific genetic mutations, including Epidermal Growth Factor Receptor (EGFR), Anaplastic Lymphoma Kinase (ALK), BRAF, and ROS1, are key targets for these treatments.
  • These targeted therapies aim to improve patient outcomes by tailoring treatment to individual tumor profiles.

Purpose of the Study:

  • To review the current evidence on targeted molecular treatments for NSCLC.
  • To summarize the efficacy, mechanisms of resistance, and safety profiles of these therapies.
  • To provide an overview of the evolving landscape of targeted therapies in NSCLC management.

Main Methods:

  • Literature review of current evidence on targeted molecular treatments for NSCLC.
  • Analysis of efficacy data for therapies targeting specific mutations (EGFR, ALK, BRAF, ROS1).
  • Examination of reported resistance mechanisms and safety data associated with these treatments.

Main Results:

  • Targeted therapies demonstrate significant efficacy in NSCLC patients with specific driver mutations.
  • Various resistance mechanisms can emerge, necessitating ongoing research and development of new strategies.
  • The safety profiles vary among different targeted agents, requiring careful patient monitoring.

Conclusions:

  • Targeted molecular treatments have become a cornerstone in NSCLC therapy, guided by specific genetic mutations.
  • Understanding resistance mechanisms is crucial for developing next-generation therapies.
  • Continued evaluation of efficacy and safety is essential for optimizing patient care in NSCLC.
Keywords:
lung cancermutationnon-small cellpersonalized therapyrearrangementtargeted therapy

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.0K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.9K
Molecular Models02:00

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.8K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K